News

The research focused on analyzing bioactive compounds from three sources: air-dried mulberry fruit (DMF), mulberry fruit juice (MFJ), and mulberry fruit pomace (MFP). This analysis included evaluating their impact on advanced glycation end-products (AGEs). The study revealed that extracts from DMF, MFJ, and MFP notably reduced AGEs in both fructose-BSA and MGO-BSA models. Compositional analysis indicated a positive correlation between phenolic content and antioxidant effectiveness. The study also explored how MFP extracts could counteract MGO-induced aging deficits in HaCaT cells.

This blog article is based on the comprehensive study conducted by Yuksel, Metz, Lohse, and Krause, providing an in-depth look at a unique case of Muckle-Wells Syndrome and its management. The article aims to disseminate these crucial findings to a broader audience, fostering greater awareness and understanding of this rare condition in the medical community and beyond.

This blog article provides an overview of the crucial findings from the study conducted by Christiane Kuschal and colleagues, offering insights into the genetic underpinnings of Trichothiodystrophy. It aims to bring this significant research to a wider audience, emphasizing its impact on the understanding and potential treatment of rare genetic disorders.

A thorough summary of Licochalcone A's pharmacological properties related to anti-aging, highlighting its antioxidant, neuroprotective, anti-aggregation, skin protective, and osteogenic activities. It delves into the mechanisms underlying these pharmacological actions to enhance understanding of the targeted pathways, offering insights into Licochalcone A's potential therapeutic uses and informing future drug development

This article delves into the genetic nuances of Crohn's Disease and Blau Syndrome, focusing on the varied impacts of CARD15/NOD2 gene mutations. It sheds light on the contrasting functional outcomes in these diseases and underscores the ongoing challenges in linking genetic insights to disease mechanisms.

Langerhans Cell Histiocytosis (LCH) presents a complex puzzle in modern medicine. This rare multisystem disease, first identified by German physician Paul Langerhans in 1865, involves a pathological proliferation of Langerhans cells - part of the monocyte-macrophage lineage. LCH's clinical spectrum is wide and heterogeneous, making diagnosis and management particularly challenging